
TY  - JOUR
TI  - SARS ORAL 2010
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S6
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7351
DO  - doi:10.1002/bjs.7351
SP  - 7
EP  - 38
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Transfusion Medicine
VL  - 5
IS  - s1
SN  - 0958-7578
UR  - https://doi.org/10.1111/j.1365-3148.1995.tb00282.x
DO  - doi:10.1111/j.1365-3148.1995.tb00282.x
SP  - 1
EP  - 55
PY  - 1995
ER  - 

TY  - JOUR
TI  - Abstracts (151 - 254)
JO  - American Journal of Transplantation
VL  - 3
IS  - s5
SN  - 1600-6135
UR  - https://doi.org/10.1034/j.1600-6143.3.s5.15.x
DO  - doi:10.1034/j.1600-6143.3.s5.15.x
SP  - 151
EP  - 254
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 181
IS  - S1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.15226
DO  - doi:10.1111/bjh.15226
SP  - 5
EP  - 211
PY  - 2018
ER  - 

TY  - JOUR
TI  - Saturday 5 April ? Respiratory Nurses SIG Oral Presentations (1030?1200)
JO  - Respirology
VL  - 8
IS  - s2
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2003.supp_1.x
DO  - doi:10.1111/j.1440-1843.2003.supp_1.x
SP  - A1
EP  - A65
PY  - 2003
ER  - 

TY  - JOUR
TI  - Arthritis & Rheumatism, 2001 Annual Scientific Meeting Abstracts, November 10–15, 2001, San Francisco, CA
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 44
IS  - S9
SN  - 0004-3591
UR  - https://doi.org/10.1002/1529-0131(200109)44:9+<::AID-ART426>3.0.CO;2-7
DO  - doi:10.1002/1529-0131(200109)44:9+<::AID-ART426>3.0.CO;2-7
SP  - 166
EP  - 276
PY  - 2001
AB  - Abstract Scientific Abstracts 679?1343
ER  - 

TY  - JOUR
TI  - ANA Poster Sessions (S1–S114)
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 60
IS  - S10
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.11489
DO  - doi:10.1002/ana.11489
SP  - S3
EP  - S34
PY  - 2006
ER  - 

TY  - JOUR
TI  - Program and Abstracts of the TWENTY-FIFTH NATIONAL MEETING of THE SOCIETY FOR LEUKOCYTE BIOLOGY
JO  - Journal of Leukocyte Biology
JA  - J Leukoc Biol
VL  - 44
IS  - 4
SN  - 0741-5400
UR  - https://doi.org/10.1002/jlb.44.4.223
DO  - doi:10.1002/jlb.44.4.223
SP  - 223
EP  - 312
PY  - 1988
ER  - 

TY  - JOUR
TI  - Print Only
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12363_3
DO  - doi:10.1111/jgh.12363_3
SP  - 694
EP  - 919
PY  - 2013
ER  - 

TY  - JOUR
TI  - Matrix Biology Europe – July 2018 Meeting Celebrating 50 years of Federation of European Connective Tissue Societies Meetings(organised by the British Society for Matrix Biology and the University of Manchester Wellcome Trust Centre for Cell-Matrix Research)
JO  - International Journal of Experimental Pathology
JA  - Int. J. Exp. Path.
VL  - 99
IS  - 6
SN  - 0959-9673
UR  - https://doi.org/10.1111/iep.12294
DO  - doi:10.1111/iep.12294
SP  - A1
EP  - A69
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 18
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.539
DO  - doi:10.1002/ejhf.539
SP  - 8
EP  - 521
PY  - 2016
ER  - 

TY  - JOUR
TI  - Free Papers
JO  - HPB
VL  - 5
IS  - s1
SN  - 1365-182X
UR  - https://doi.org/10.1080/13651820310001291
DO  - doi:10.1080/13651820310001291
SP  - 23
EP  - 87
PY  - 2003
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 52
IS  - S47
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.23840
DO  - doi:10.1002/ppul.23840
SP  - S214
EP  - S516
PY  - 2017
ER  - 

TY  - JOUR
AU  - Bailey, Damian M.
AU  - Brugniaux, Julien V.
AU  - Filipponi, Teresa
AU  - Marley, Christopher J.
AU  - Stacey, Benjamin
AU  - Soria, Rodrigo
AU  - Rimoldi, Stefano F.
AU  - Cerny, David
AU  - Rexhaj, Emrush
AU  - Pratali, Lorenza
AU  - Salmòn, Carlos Salinas
AU  - Murillo Jáuregui, Carla
AU  - Villena, Mercedes
AU  - Smirl, Jonathan D.
AU  - Ogoh, Shigehiko
AU  - Pietri, Sylvia
AU  - Scherrer, Urs
AU  - Sartori, Claudio
TI  - Exaggerated systemic oxidative-inflammatory-nitrosative stress in chronic mountain sickness is associated with cognitive decline and depression
JO  - The Journal of Physiology
JA  - J Physiol
VL  - 597
IS  - 2
SN  - 0022-3751
UR  - https://doi.org/10.1113/JP276898
DO  - doi:10.1113/JP276898
SP  - 611
EP  - 629
KW  - chronic mountain sickness
KW  - free radicals
KW  - cerebrovascular function
KW  - cognition
KW  - dementia
KW  - depression
PY  - 2019
AB  - Key points Chronic mountain sickness (CMS) is a maladaptation syndrome encountered at high altitude (HA) characterised by severe hypoxaemia that carries a higher risk of stroke and migraine and is associated with increased morbidity and mortality. We examined if exaggerated oxidative-inflammatory-nitrosative stress (OXINOS) and corresponding decrease in vascular nitric oxide bioavailability in patients with CMS (CMS+) is associated with impaired cerebrovascular function and adverse neurological outcome. Systemic OXINOS was markedly elevated in CMS+ compared to healthy HA (CMS?) and low-altitude controls. OXINOS was associated with blunted cerebral perfusion and vasoreactivity to hypercapnia, impaired cognition and, in CMS+, symptoms of depression. These findings are the first to suggest that a physiological continuum exists for hypoxaemia-induced systemic OXINOS in HA dwellers that when excessive is associated with accelerated cognitive decline and depression, helping identify those in need of more specialist neurological assessment and targeted support. Abstract Chronic mountain sickness (CMS) is a maladaptation syndrome encountered at high altitude (HA) characterised by severe hypoxaemia that carries a higher risk of stroke and migraine and is associated with increased morbidity and mortality. The present cross-sectional study examined to what extent exaggerated systemic oxidative-inflammatory-nitrosative stress (OXINOS), defined by an increase in free radical formation and corresponding decrease in vascular nitric oxide (NO) bioavailability, is associated with impaired cerebrovascular function, accelerated cognitive decline and depression in CMS. Venous blood was obtained from healthy male lowlanders (80 m, n = 17), and age- and gender-matched HA dwellers born and bred in La Paz, Bolivia (3600 m) with (CMS+, n = 23) and without (CMS?, n = 14) CMS. We sampled blood for oxidative (electron paramagnetic resonance spectroscopy, HPLC), nitrosative (ozone-based chemiluminescence) and inflammatory (fluorescence) biomarkers. We employed transcranial Doppler ultrasound to measure cerebral blood flow (CBF) and reactivity. We utilised psychometric tests and validated questionnaires to assess cognition and depression. Highlanders exhibited elevated systemic OXINOS (P < 0.05 vs. lowlanders) that was especially exaggerated in the more hypoxaemic CMS+ patients (P < 0.05 vs. CMS?). OXINOS was associated with blunted cerebral perfusion and vasoreactivity to hypercapnia, impaired cognition and, in CMS+, symptoms of depression. Collectively, these findings are the first to suggest that a physiological continuum exists for hypoxaemia-induced OXINOS in HA dwellers that when excessive is associated with accelerated cognitive decline and depression, helping identify those in need of specialist neurological assessment and support.
ER  - 

TY  - JOUR
TI  - Posters
JO  - Basic & Clinical Pharmacology & Toxicology
VL  - 105
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/j.1742-7843.2009.00437.x
DO  - doi:10.1111/j.1742-7843.2009.00437.x
SP  - 44
EP  - 150
PY  - 2009
ER  - 

TY  - JOUR
TI  - 45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Zurich, Switzerland, March 7-10, 2018
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 27
IS  - 3
SN  - 0906-6705
UR  - https://doi.org/10.1111/exd.13486
DO  - doi:10.1111/exd.13486
SP  - e2
EP  - e106
PY  - 2018
ER  - 

TY  - JOUR
AU  - Lombard Ph.D., Julian H.
TI  - Abstracts for the 8th World Congress for Microcirculation August 15-19, 2007 Milwaukee, Wisconsin, USA
JO  - Microcirculation
JA  - Microcirculation
VL  - 14
IS  - 4‐5
SN  - 1073-9688
UR  - https://doi.org/10.1080/10739680701413573
DO  - doi:10.1080/10739680701413573
SP  - 439
EP  - 569
PY  - 2007
ER  - 

C7  - pp. 163-214
TI  - Role of Metabolism in Drug Toxicity
SN  - 9780470863527
UR  - https://doi.org/10.1002/0470032669.ch8
DO  - doi:10.1002/0470032669.ch8
SP  - 163-214
KW  - metabolism role in drug toxicity
KW  - Reversible drug adverse effects: Type A
KW  - drug metabolism-related changes
KW  - Darling–Roughton effect and methaemoglobin
KW  - acute methaemoglobinaemia
KW  - irreversible toxicity (Type B)
KW  - Type B1: necrotic reactions
KW  - tacrine toxicity
KW  - Troglitazone mechanisms of toxicity
KW  - dietary carcinogens
PY  - 2007
AB  - Summary This chapter contains sections titled: Adverse drug reactions: definitions Reversible drug adverse effects: Type A Irreversible toxicity (Type B) Type B1 necrotic reactions Type B2 reactions: immunotoxicity Type B3 reactions: role of metabolism in cancer Summary of biotransformational toxicity
ER  - 

TY  - JOUR
C7  - 1970269
TI  - Contents: (Adv. Funct. Mater. 39/2019)
JO  - Advanced Functional Materials
JA  - Adv. Funct. Mater.
VL  - 29
IS  - 39
SN  - 9780470863527
UR  - https://doi.org/10.1002/adfm.201970269
DO  - doi:10.1002/adfm.201970269
SP  - 1970269
PY  - 2019
ER  - 

TY  - JOUR
AU  - Maccarrone, Mauro
AU  - Catani, Maria Valeria
AU  - Iraci, Stefano
AU  - Melino, Gerry
AU  - Agrò, Alessandro Finazzi
TI  - A survey of reactive oxygen species and their role in dermatology
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 8
IS  - 3
SN  - 9780470863527
UR  - https://doi.org/10.1111/j.1468-3083.1997.tb00478.x
DO  - doi:10.1111/j.1468-3083.1997.tb00478.x
SP  - 185
EP  - 202
KW  - Reactive oxygen species
KW  - Dermatology
KW  - Antioxidant enzymes
KW  - Antiradical molecules
PY  - 1997
AB  - Abstract General description It this paper we present a survey of the main reactive oxygen species (ROS). their biological sources and the array of antioxidant enzymes and antiradical molecules which constitutes the cellular detent; against ROS toxicity. We outline also the fundamentals of ROS biochemistry, in relation to the role of ROS in several human pathologies. Finally, we discuss with particular emphasis the involvement of ROS in dermatological diseases, highlighting the possible therapeutic application of antioxidants in skin care. Learning objective The reader will learn what ROS are, the identity of the anti-ROS defensive system in human cells and the many fold roles of ROS in human physiopathology, and thus the potential application of antioxidants in clinical therapy.
ER  - 
